Study of inhaled ALX1 for adults with bronchiectasis
Part of Lungs & breathing clinical trials.
This trial tests an inhaled medicine called ALX1 for adults with bronchiectasis. It looks at whether the drug can help reduce lung infections and improve mucus clearance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You cough up mucus every day and can provide sputum samples during the study.
- You have bronchiectasis from conditions like cystic fibrosis, COPD, or other causes, confirmed by a CT scan.
- You have had at least one lung infection treated with antibiotics in the last 2 years.
- You have not coughed up more than about 2 tablespoons of blood in the last month.
- You are not using certain antibiotics or other lung medications, or you have been on a stable dose for a while (3 months or more).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called CTX-187 in two groups: healthy volunteers (Parts A and B) and people with chronic lung infection from bronchiectasis (Part C). It helps find the right dose and checks safety.
This trial tests the LibAirty system, a device that helps clear mucus from your lungs, in people with bronchiectasis. Participants use the device at home to see how well it works in daily life.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
Hear when a new Bronchiectasis Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.